Search Results - "Iglesias Gómez, Alicia"
-
1
Dose reduction of efavirenz: an observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics
Published in Pharmacogenomics (01-05-2014)“…Antiretroviral treatment implies a high cost to the healthcare system. The aim of this study was to evaluate the clinical and economic impact of efavirenz…”
Get more information
Journal Article -
2
CYP3A4 Polymorphism and Lopinavir Toxicity in an HIV-Infected Pregnant Woman
Published in Clinical drug investigation (2015)“…Cytochrome P450 (CYP) 3A4 has been considered to be the most important enzyme system for metabolism of lopinavir/ritonavir (LPV/r), a widely used HIV protease…”
Get full text
Journal Article -
3
Spontaneous Pneumothorax in Wegener's Granulomatosis: Case Report and Literature Review
Published in Seminars in arthritis and rheumatism (01-12-2011)“…Background Pulmonary manifestations of Wegener's granulomatosis (WG) are present in 45% of cases at the onset of the disease, and they reach 85% of the…”
Get full text
Journal Article -
4
Impact of a pharmaceutical care program on clinical evolution and antiretroviral treatment adherence: a 5-year study
Published in Patient preference and adherence (01-01-2013)“…Antiretroviral treatments (ART) form the basis of adequate clinical control in human immunodeficiency virus-infected patients, and adherence plays a primary…”
Get full text
Journal Article -
5
Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV
Published in Clinical drug investigation (01-01-2010)“…A 48-year-old Caucasian male patient presented with severe adverse drug events (ADEs) while being treated with a standard dose (600 mg/day) of efavirenz. The…”
Get full text
Journal Article -
6
Health-related quality of life, pain and sleep in patients with HIV depending on the clinical situation: A cross-sectional pilot study
Published in Tropical medicine and infectious disease (30-11-2022)“…Introduction: Health-related quality of life (HRQL), pain and sleep have been described as relevant traits in patients with human immunodeficiency virus (HIV)…”
Get full text
Journal Article -
7
Real-life experience of hepatitis C treatment in a Spanish prison
Published in Revista española de quimioterapia (01-06-2022)“…Hepatitis C virus (HCV) infection is a major public health problem that causes multiple comorbidities. People in prisons who inject intravenous drugs are at…”
Get full text
Journal Article -
8
Dysgeusia as an adverse reaction to praziquantel
Published in Drug and chemical toxicology (New York, N.Y. 1978) (01-01-2012)Get full text
Journal Article -
9
Management of cystic echinococcosis in the last two decades: what have we learned?
Published in Transactions of the Royal Society of Tropical Medicine and Hygiene (01-05-2018)“…Management options for cystic echinococcosis (CE) remain a serious problem. The main aim of this study was to examine the selection and complications of…”
Get full text
Journal Article -
10
Cardiovascular risk in HIV-infected women
Published in Atherosclerosis (01-08-2017)Get full text
Journal Article -
11
1262. Dolutegravir Plus 3TC In Antiretroviral Experienced Adults: Immunovirological Outcomes In a Multicenter Retrospective Cohort In Spain
Published in Open forum infectious diseases (15-12-2022)“…Abstract Background Dolutegravir-based dual therapies for treating people living with HIV (PLHIV) are strategies strongly recommended in several practice…”
Get full text
Journal Article -
12
Acute pancreatitis and obstructive jaundice secondary to metastases from lung cancer
Published in Gastroenterología y hepatología (01-12-2009)“…Lung cancer is one of the most frequent neoplasms. The symptoms are due to the cancer itself, its extension, and associated paraneoplastic syndromes. Although…”
Get more information
Journal Article -
13
Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV
Published in Clinical drug investigation (01-06-2010)“…A 48-year-old Caucasian male patient presented with severe adverse drug events (ADEs) while being treated with a standard dose (600 mg/day) of efavirenz. The…”
Get full text
Journal Article -
14
Fever of unknown origin as the first manifestation of colonic pathology
Published in Clinical medicine (London, England) (01-04-2013)“…Fever of unknown origin (FUO) is an entity caused by more than 200 diseases. Haematologic neoplasms are the most common malignant cause of FUO. Fever as a…”
Get full text
Journal Article -
15
Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a caucasian patient with HIV
Published in Clinical drug investigation (01-06-2010)“…A 48 -year-old Caucasian male patient presented with severe adverse drug events (ADEs) while being treated with a standard dose (600mg/day) of efavirenz. The…”
Get full text
Journal Article -
16
Dysgeusia as an adverse reaction to praziquantel
Published in Drug and Chemical Toxicology (01-01-2012)Get full text
Report